SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001662252-18-000036
Filing Date
2018-02-20
Accepted
2018-02-20 14:55:55
Documents
55
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q rcha10q123117.htm 10-Q 414655
2 EX-31.1 ex31_1.htm EX-31.1 8621
3 EX-31.2 ex31_2.htm EX-31.2 8663
4 EX-32.1 ex32_1.htm EX-32.1 3634
  Complete submission text file 0001662252-18-000036.txt   3609423

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE rcha-20171231.xml EX-101.INS 610277
6 XBRL SCHEMA FILE rcha-20171231.xsd EX-101.SCH 60485
7 XBRL CALCULATION FILE rcha-20171231_cal.xml EX-101.CAL 32296
8 XBRL DEFINITION FILE rcha-20171231_def.xml EX-101.DEF 160782
9 XBRL LABEL FILE rcha-20171231_lab.xml EX-101.LAB 252512
10 XBRL PRESENTATION FILE rcha-20171231_pre.xml EX-101.PRE 241599
Mailing Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212
Business Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212 (424) 230-7001
Rich Pharmaceuticals, Inc. (Filer) CIK: 0001504389 (see all company filings)

IRS No.: 463259117 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-54767 | Film No.: 18624273
SIC: 2834 Pharmaceutical Preparations